Menopause
Depomed Initiates Dosing of Patients In Phase 2 Trial for Gabapentin Gr for the Treatment of Menopausal Hot Flashes
Published in Biotech Law Weekly, July 6th, 2007
"We are very excited to have dosed the first patient. Following up on the clinical trial kick-off meeting we held in April, we screened approximately 40 patients last week and dosed four patients yesterday," said Carl Pelzel, executive vice president and chief operating officer of Depomed. "Even though there have been several previous trials conducted by other investigators, these trials varied considerably in design, including the doses evaluated. We designed our Phase 2 trial as a PK/PD trial to study the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-07-06)
More Articles from Biotech Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Closes $40 Million Common Stock Offering; Underwriters Exercise Full over-Allotment Option - AARP
Leading New York Physician Calls on Legislature to Pass Rx Gift Disclosure Legislation - AARP
Senior Advocates Join to Say 'No Way' to 'No-Growth' Budget - Acusphere, Inc.
Acusphere Announces Closing of Common Stock and Warrant Offering - Alliance of Specialty Medicine
Nation's Medical Specialists Applaud House Action to Establish Clear and Valid Approach to Physician Reporting on Quality Measures - America's Second Harvest-The Nation's Food Bank Network
House Subcommittee Markup Provides Hope for Millions of Hungry Americans - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
